https://media.ideayabio.com/ https://media.ideayabio.com/2026-08-04-IDEAYA-Biosciences-Reports-Second-Quarter-2026-Financial-Results-and-Provides-Business-Update Tue, 04 Aug 2026 06:00:00 -0400 https://media.ideayabio.com/2026-08-04-IDEAYA-Biosciences-Reports-Second-Quarter-2026-Financial-Results-and-Provides-Business-Update https://media.ideayabio.com/2026-07-31-IDEAYA-Biosciences-Announces-Inducement-Grants-under-Nasdaq-Listing-Rule-5635-c-4 Fri, 31 Jul 2026 06:00:00 -0400 https://media.ideayabio.com/2026-07-31-IDEAYA-Biosciences-Announces-Inducement-Grants-under-Nasdaq-Listing-Rule-5635-c-4 https://media.ideayabio.com/2026-07-27-IDEAYA-Biosciences-Announces-IDE892,-a-Potential-Best-in-Class-MTA-Cooperative-PRMT5-Inhibitor,-Initiates-Part-2-Monotherapy-Expansion-in-the-Phase-1-2-Study-in-MTAP-Deleted-Pancreatic-and-Lung-Cancers Mon, 27 Jul 2026 06:00:00 -0400 https://media.ideayabio.com/2026-07-27-IDEAYA-Biosciences-Announces-IDE892,-a-Potential-Best-in-Class-MTA-Cooperative-PRMT5-Inhibitor,-Initiates-Part-2-Monotherapy-Expansion-in-the-Phase-1-2-Study-in-MTAP-Deleted-Pancreatic-and-Lung-Cancers https://media.ideayabio.com/2026-07-17-IDEAYA-Biosciences-Announces-ESMO-2026-Presentations-for-Darovasertib-and-IDE849-Clinical-Programs Fri, 17 Jul 2026 09:00:00 -0400 https://media.ideayabio.com/2026-07-17-IDEAYA-Biosciences-Announces-ESMO-2026-Presentations-for-Darovasertib-and-IDE849-Clinical-Programs https://media.ideayabio.com/2026-06-26-IDEAYA-Biosciences-Announces-Inducement-Grants-under-Nasdaq-Listing-Rule-5635-c-4 Fri, 26 Jun 2026 06:00:00 -0400 https://media.ideayabio.com/2026-06-26-IDEAYA-Biosciences-Announces-Inducement-Grants-under-Nasdaq-Listing-Rule-5635-c-4